9. What informed consent procedures are used?
County administrator interviews, treatment program surveys,
focus groups, and client interviews include formal informed
consent procedures reviewed and approved by the UCLA Institutional
Review Board. Each participant will be given an informed
consent information packet that describes the participant
selection criteria, purpose and nature of the research activity
(e.g., interview, focus group, survey), and the measures
taken to protect the confidentiality of the responses. The
participant is invited to voluntarily participate in the
study. Once the interviewer or focus group moderator has
covered the form, the participant is asked to give written
or verbal consent if he or she wishes to participate in
the study. (Program administrators are not asked to sign
the informed consent form. The return of their questionnaires
serves as an indication of the administrators’ agreement
to participate in the study.)
10. Are interviewers and focus group moderators
trained to have the skills and sensitivity to protect confidentiality?
The focus group moderators and interviewers for the follow-up
study are well trained on the research protocol, informed
consent procedures, and confidentiality, are experienced
in these data collection methods, and have worked on similar
studies at UCLA ISAP.
11. How will follow-up tracking be conducted to
ensure confidentiality?
The 3- and 12-month follow-up interviews will require that
study staff track and locate participants. UCLA ISAP has
developed procedures that result in high percentages of
participants being located, as described in the Staying
in Touch manual available at: http://www.uclaisap.org/trackingmanual/index.html.
Tracking information will be gathered voluntarily from
the participants during the initial interview. TSI study
staff and county/treatment staff will ask participants to
provide full names and aliases; date of birth; place of
birth; residence address and phone; best mailing address
and phone number; work address and phone number; name, address,
and phone numbers of all immediate family and friends, case
worker, clinic, doctor, or other regular contact/agency.
This information will be the primary source of the tracking
and locating conducted.
Follow-up interview tracking will begin with a letter mailed
to the last known address, requesting that the person contact
study staff regarding a “health study.” No details
of the project, why the person was recruited, or the nature
of the follow-up will be included in the letter, in case
it is opened by persons other than the participant. Any
follow-up phone calls to persons other than the participant
will discuss the study vaguely in terms of a “health
study.” No other information will be given to persons
other than the participant.
If the information provided by the client does not lead
to contact, study staff will search publicly available records
for additional follow-up leads. UCLA may ask county staff
or treatment providers to assist with tracking and locating.
12. How will information about research findings
be disseminated?
We will provide periodic reports on aggregate-level data
across counties and programs. We plan to periodically brief
the treatment communities and policymakers at the local,
state, and national levels on the study findings. Information
about the study will also be available on the Proposition
36 Treatment System Impact (TSI) Study web site: www.uclaisap.org/Prop36/TSI.
Initial results are published in Evaluation Review and are
available at: http://www.uclaisap.org/Prop36/TSI/publications.html.